Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$17.37 - $26.27 $781,650 - $1.18 Million
-45,000 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$10.65 - $25.75 $716,745 - $1.73 Million
-67,300 Reduced 59.93%
45,000 $1.05 Million
Q4 2018

Feb 14, 2019

SELL
$9.26 - $16.38 $18,520 - $32,759
-2,000 Reduced 1.75%
112,300 $1.24 Million
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $861,822 - $2.09 Million
114,300 New
114,300 $1.91 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.